-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Purpose: Interstitial lung disease (ILD) is one of the most common extra-articular complications of rheumatoid arthritis ( RA )
.
The MUC5B promoter variant rs35705950 is an important risk factor for inherited ILD .
Objective: interstitial lung disease (ILD) is one of the most common rheumatoid arthritis ( rheumatoid arthritis RA outer) articular complications
Methods: FinnGen is a collection of epidemiological cohorts and hospital biobank samples, combining genetic data with 50 years of follow-up by the
Results: 293 972 individuals were in 1965 Ming (0.
7%) in 80 developing at the age of ILD
Conclusion: The results of this study provide lifetime risk estimates of RA-ILD based on the status of MUC5B MUC5B mutation carriers , and demonstrate the potential of genomics for RA-ILD risk stratification .
Further research is needed to investigate the effect of MUC5B and MUC5B on RA-ILD results .
Source:
Source:Palomäki A, et al.
Ann Rheum Dis 2021;80:1530–1536.
doi:10.
Leave a message here